Chapter 10 Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis

Progress in Brain Research

Volumn 120, Issue C, 1999, Pages 119-132

  Jacobson, Kenneth A ^a   Hoffmann, Carsten ^a   Kim, Yong Chul ^a   Camaioni, Emidio ^a   Nandanan, Erathodiyil ^a   Jang, Soo Yeon ^a   Guo, Dan Ping ^a   Ji, Xiao duo ^a   Kügelgen, Ivar von ^a   Moro, Stefano ^a   Ziganshin, Airat U ^b   Rychkov, Alexei ^b   King, Brian F ^c   Brown, Sean G ^c   Wildman, Scott S ^c   Burnstock, Geoffrey ^c   Boyer, Jose L ^d   Mohanram, Arvind ^d   Harden, T Kendall ^d  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; DISULFIDE; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; HUMAN; LIGAND BINDING; MOLECULAR MODEL; MOLECULAR RECOGNITION; PHARMACOPHORE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0032866557     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)63550-5     Document Type: Article

References (25)

1. Boyer, J.L., Zohn, I.E., Jacobson, K.A., Harden, T.K., Differential effects of P2–purinergic receptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y purinergic receptors. Br. J. Pharmacol. 113 (1994), 614-620.
2. Boyer, J.L., Siddiqi, S., Fischer, B., Romera-Avila, T., Jacobson, K.A., Harden, T.K., Identification of potent P2Y purinoceptor agonists that are derivatives of adenosine 5′-monophosphate. Br. J. Pharmacol. 118 (1996), 1959-1964.
3. Boyer, J.L., Romero-Avila, T., Schachter, J.B., Harden, T.K., Identification of competitive antagonists of the P2Y1 receptor. Mol. Pharmacol. 50 (1996), 1323-1329.
4. Boyer, J.L., Mohanram, A., Camaioni, E., Jacobson, K.A., Harden, T.K., Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate. Br. J. Pharmacol. 124 (1998), 1-3.
5. Camaioni, E., Boyer, J.L., Mohanram, A., Harden, T.K., Jacobson, K.A., Deoxyadenosine-bisphosphate derivatives as potent antagonists at P2Y1 receptors. J. Med. Chem. 41 (1998), 183-190.
6. Charlton, S.J., Brown, C.A., Weisman, G.A., Turner, J.T., Erb, L., Boarder, M.R., PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors. Br. J. Pharmacol. 118 (1996), 704-710.
7. Communi, D., Motte, S., Boeynaems, J.-M., Pirroton, S., Pharmacological characterization of the human P2Y4 receptor. Eur. J. Pharmacol. 317 (1996), 383-389.
8. Communi, D., Govaerts, C., Parmentier, M., Boeynaems, J.-M., Cloning of a Human P2 Receptor Coupled to Phospholipase C and Adenylyl Cyclase. J. Biol. Chem. 272 (1997), 31969-31973.
9. Erb, L., Garrad, R., Wang, Y.J., Quinn, T., Turner, J.T., Weisman, G.A., Site-directed mutagenesis of P2U purinoceptors–positively charged amino-acids in transmembrane helix-6 and helix-7 affect agonist potency and specificity. J. Biol. Chem. 270 (1995), 4185-4188.
10. Fredholm, B.B., Abbracchio, M.P., Burnstock, G., Daly, J.W., Harden, T.K., Jacobson, K.A., Leff, P., Williams, M., Nomenclature and classification of purinoceptors: A report from the IUPHAR subcommittee. Pharmacol Rev. 46 (1994), 143-156.
11. Guo, D., Moro, S., Von Kügelgen, I., Kim, Y.-C., Jacobson, K.A., Recognition of pyridoxal phosphate-related antagonists occurs within transmembrane domains of the human P2Y1 receptor. Faseb J., 12, 1999, A465 Abstract 390.9.
12. Harden, T.K., Hawkins, P.T., Stephens, L., Boyer, J.L., Downes, P., Phosphoinositide hydrolysis by guanosine 5′-(γ-thio)triphosphate-activated phospholipase C of turkey erythrocyte membranes. Biochem. J. 252 (1988), 583-593.
13. C. Hoffmann, S. Moro, R.A. Nicholas, T.K. Harden, K.A. Jacobson, (1999) The role of amino acids of the extracellular loops of the human P2Y1 receptor in surface expression and activation processes. J. Biol. Chem., in press.
14. Jacobson, K.A., Kim, Y.-C., Wildman, S.S., Mohanram, A., Harden, T.K., Boyer, J.L., King, B.F., Burnstock, G., A pyridoxine cyclic-phosphate and its 6-arylazo-derivative selectively potentiate and antagonize activation of P2X1 receptors. J. Med. Chem. 41 (1998), 2201-2206.
15. Jiang, Q., Guo, D., Lee, B.X., van Rhee, A.M., Kim, Y.C., Nicholas, R., Schachter, J., Harden, T.K., Jacobson, K.A., Mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor. Mol. Pharmacol. 52 (1997), 499-507.
16. Kim, Y.-C., Camaioni, E., Ziganshin, A.U., Ji, X.-J., King, B.F., Wildman, S.S., Rychkov, A., Yoburn, J., Kim, H., Mohanram, A., Harden, T.K., Boyer, J.L., Burnstock, G., Jacobson, K.A., Synthesis and structure activity relationships of pyridoxal-6-azoaryl-5′-phosphate and phosphonate derivatives as P2 receptor antagonists. Drug Devel. Res. 45 (1998), 52-66.
17. Lambrecht, G., Friebe, T., Grimm, U., Windscheif, U., Bungardt, E., Hildebrandt, C., Baumert, H.G., Spatzkumbel, G., Mutschler, E., PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur. J. Pharmacol. 217 (1992), 217-219.
18. Moro, S., Guo, D., Camaioni, E., Boyer, J.L., Harden, T.K., Jacobson, K.A., Human P2Y1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J. Med. Chem. 41 (1998), 1456-1466.
19. Moro, S., Hoffmann, C., Jacobson, K.A., Role of the extracellular loops of G protein-coupled receptors in ligand recognition: A molecular modeling study of the human P2Y1 receptor. Biochemistry 38 (1999), 3498-3507.
20. E. Nandanan, E. Camaioni, S.Y. Jang, Y.-C. Kim, G. Cristalli, P. Herdewijn, J.A. Secrist, K.N. Tiwari, A. Mohanram, T.K. Harden, J.L. Boyer, K.A. Jacobson, (1999) Structure activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. J. Med. Chem., in press.
21. North, R.A., Barnard, E.A., Nucleotide receptors. Current Opinion in Neurobiol. 7 (1997), 346-357.
22. Robaye, B., Boeynaems, J.-M., Communi, D., Slow desensitization of the human P2Y6 receptor. Eur. J. Pharmacol. 329 (1997), 231-236.
23. Schachter, J.B., Li, Q., Boyer, J.L., Nicholas, R.A., Harden, T.K., Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br. J. Pharmacol. 118 (1996), 167-173.
24. van Rhee, A.M., Jacobson, K.A., Molecular architecture of G protein-coupled receptors. Drug Devel. Res. 37 (1996), 1-38.
25. van Rhee, A.M., Jacobson, K.A., Garrad, R., Weisman, G.A., Erb, L., P2 receptor modeling and identification of ligand binding sites. Turner, J.T., Weisman, G., Fedan, J., (eds.) The P2 Nucleotide Receptors, in the series “The Receptors”, 1997, Humana Press, Clifton, New Jersey, 135-166.